14158 Results (Page 538 of 567)
All Market Research Reports
UAE Hypersomnia Therapeutics Market Analysis
The UAE Hypersomnia Therapeutics Market was valued at $41.83 Mn in 2023 and is predicted to grow at a CAGR of 7.50% from 2023 to 2030, to $69.39 Mn by 2030. The key drivers of this industry include the rising prevalence of sleep disorders, expanding geriatric population, early detection, and advancement in diagnostic tools. The key players in the industry are Teva, Jazz Pharmaceuticals, and Neopharma among others.
Saudi Arabia Chronic Cough Therapeutics Market Analysis
Saudi Arabia Chronic Cough Therapeutics Market was valued at $107 Mn in 2022 and is estimated to reach $223 Mn in 2030, exhibiting a CAGR of 9.6% during the forecast period. The primary factor fuelling the expansion of the chronic cough therapeutics market is the widespread occurrence of chronic respiratory infections, as the presence of such conditions is frequently indicated by chronic cough. Currently, major players in this market include GlaxoSmithKline (GSK), Pfizer, McNeil Consumer Healthcare (Johnson & Johnson), Procter & Gamble (P&G), Reckitt Benckiser Group, Perrigo Company, Medtech Products Inc., Bionpharma Inc., A. Vogel Canada Inc., and Jamieson Laboratories.
Spain MRI Market Analysis
The Spain MRI Market was valued at $128.15 Mn in 2023 and is predicted to grow at a CAGR of 5.5% from 2023 to 2030, to $186.42 Mn by 2030. The key drivers of this industry include rising prevalence of chronic diseases, increasing healthcare expenditure, and growing demand for early and accurate detection. The key players in the industry are GE Healthcare, Esaote, Hologic Inc., and PerkinElmer Inc. among others.
Brazil Hypersomnia Therapeutics Market Analysis
The Brazil Hypersomnia Therapeutics Market was valued at $142.96 Mn in 2023 and is predicted to grow at a CAGR of 5.0% from 2023 to 2030, to $201.17 Mn by 2030. The key drivers of this industry include the rising prevalence of sleep disorders, expanding geriatric population, early detection, and advancement in diagnostic tools. The key players in the industry are Teva, Takeda, and Merck, Jazz Pharmaceuticals among others.
Singapore Chronic Cough Therapeutics Market Analysis
Singapore Chronic Cough Therapeutics Market was valued at $8 Mn in 2022 and is estimated to reach $15 Mn in 2030, exhibiting a CAGR of 8.7% during the forecast period. The predominant factor driving the growth of the chronic cough therapeutics market is the prevalent occurrence of persistent coughing associated with chronic respiratory infections. Leading entities in this sector currently include Pfizer, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, AstraZeneca, Boehringer Ingelheim, Teva Pharmaceuticals, Hikma Pharmaceuticals, and Abbott Laboratories.
UK MRI Market Analysis
The UK MRI Market was valued at $172.64 Mn in 2023 and is predicted to grow at a CAGR of 4.5% from 2023 to 2030, to $234.94 Mn by 2030. The key drivers of this industry include increasing prevalence of chronic diseases, rise in healthcare expenditure, and increasing awareness for early and accurate diagnosis. The key players in the industry are GE Healthcare, Philips Healthcare, Siemens Healthineers, and Vista Health among others.
Canada Dental Implant Market Analysis
Canada Dental Implant Market was valued at $399.20 Mn in 2023 and is predicted to grow at a CAGR of 9.8% from 2023 to 2030, to $768.10 Mn by 2030. The key drivers of this industry include like growing demand for aesthetics, growing dental awareness, a growing aging population, and improved dental infrastructure. The industry is primarily dominated by Straumann Group, Dentsply Sirona, Zimmer Biomet Ltd, and Henry Schein Holdings Ltd among others.
Mexico Hypersomnia Therapeutics Market Analysis
The Mexico Hypersomnia Therapeutics Market was valued at $13.80 Mn in 2023 and is predicted to grow at a CAGR of 4.5% from 2023 to 2030, to $18.78 Mn by 2030. The key drivers of this industry include the rising prevalence of sleep disorders, expanding geriatric population, early detection, and advancement in diagnostic tools. The key players in the industry are Sanofi, Pfizer, Merck, and Laboratorios Sanfer among others.
South Africa Chronic Cough Therapeutics Market Analysis
South Africa Chronic Cough Therapeutics Market was valued at $41 Mn in 2022 and is estimated to reach $84 Mn in 2030, exhibiting a CAGR of 9.33% during the forecast period. The primary catalyst propelling the expansion of the chronic cough therapeutics market is the widespread prevalence of persistent coughing linked to chronic respiratory infections. Key players in this industry comprise Aspen Pharmacare, Pfizer, GlaxoSmithKline, Johnson & Johnson, Novartis, Sanofi, Merck & Co., AstraZeneca, Abbott Laboratories, and Chiesi Farmaceutici.
China MRI Market Analysis
The China MRI Market was valued at $533.77 Mn in 2023 and is predicted to grow at a CAGR of 8% from 2023 to 2030, to $914.79 Mn by 2030. The key drivers of this industry include the rise in geriatric population, rising burden of chronic diseases, and technological advancements in MRI. The key players in the industry are GE Healthcare, Koninklijke Philips NV, Shenzhen Basda Medical Apparatus, and United Imaging Healthcare among others.
US Dental Implant Market Analysis
US Dental Implant Market was valued at $2,095.80 Mn in 2023 and is predicted to grow at a CAGR of 7.8% from 2023 to 2030, to $3,545.5 Mn by 2030. The key drivers of this industry include rising demand for aesthetics, a growing aging population, growing awareness of benefits, and improved dental technology. The industry is primarily dominated by Straumann Group, Dentsply Sirona, Zimmer Biomet Ltd, and Henry Schein Holdings Ltd among others.
France Hypersomnia Therapeutics Market Analysis
The France Hypersomnia Therapeutics Market was valued at $11.50 Mn in 2023 and is predicted to grow at a CAGR of 4.73% from 2023 to 2030, to $15.89 Mn by 2030. The key drivers of this industry include the rising prevalence of sleep disorders, expanding geriatric population, early detection, and advancement in diagnostic tools. The key players in the industry are Jazz Pharmaceuticals, Pfizer, Takeda, and Novartis among others
Spain Chronic Cough Therapeutics Market Analysis
Spain Chronic Cough Therapeutics Market was valued at $122 Mn in 2022 and is estimated to reach $210 Mn in 2030, exhibiting a CAGR of 7.1% during the forecast period. The primary factor propelling the expansion of the chronic cough therapeutics market is the widespread occurrence of chronic respiratory infections, commonly indicated by the presence of persistent coughing. Currently, prominent players in this market include Boiron, AstraZeneca, GlaxoSmithKline, Sanofi, Pfizer, Merck, Johnson & Johnson, Novartis, Teva Pharmaceutical Industries, and Pierre Fabre Laboratories.
Indonesia MRI Market Analysis
The Indonesia MRI Market was valued at $39.84 Mn in 2023 and is predicted to grow at a CAGR of 6.5% from 2023 to 2030, to $61.91 Mn by 2030. The key drivers of this industry include the rise in mobile MRI units, increased focus on early detection, and rising prevalence of chronic disease. The key players in the industry are GE Healthcare, Esaote, Neusoft Medical Systems, and Fonar Corporation among others.
Saudi Arabia Dental Implant Market Analysis
Saudi Arabia Dental Implant Market was valued at $84.80 Mn in 2023 and is predicted to grow at a CAGR of 11.3% from 2023 to 2030, to $179.50 Mn by 2030. The key drivers of this industry include growing demand for aesthetics, growing dental awareness, medical tourism potential, and improved dental infrastructure. The industry is primarily dominated by Straumann Group, Dentsply Sirona, Zimmer Biomet Ltd, and Henry Schein Holdings Ltd among others.
Germany Hypersomnia Therapeutics Market Analysis
The Germany Hypersomnia Therapeutics Market was valued at $5.06 Mn in 2023 and is predicted to grow at a CAGR of 5% from 2023 to 2030, to $7.12 Mn by 2030. The key drivers of this industry include the rising prevalence of sleep disorders, expanding geriatric population, early detection, and advancement in diagnostic tools. The key players in the industry are Janssen, Novartis, Pfizer, and Sanofi among others.
UAE Chronic Cough Therapeutics Market Analysis
UAE Chronic Cough Therapeutics Market was valued at $32 Mn in 2022 and is estimated to reach $63 Mn in 2030, exhibiting a CAGR of 9.1% during the forecast period. The main driver behind the growth of the chronic cough therapeutics market is the extensive prevalence of chronic respiratory infections, often signaled by the occurrence of chronic cough. Presently, key participants in this market consist of GlaxoSmithKline (GSK), Pfizer, McNeil Consumer Healthcare (Johnson & Johnson), Procter & Gamble (P&G), Reckitt Benckiser Group, Perrigo Company, Medtech Products Inc., Bionpharma Inc., A. Vogel Canada Inc., and Jamieson Laboratories.
Japan MRI Market Analysis
The Japan MRI Market was valued at $412.73 Mn in 2023 and is predicted to grow at a CAGR of 7% from 2023 to 2030, to $662.76 Mn by 2030. The key drivers of this industry include increasing prevalence of chronic diseases, affordability, and growing government expenditure. The key players in the industry are Siemens Healthineers, GE Healthcare, Elekta AB, and Koninklijke Philips NV among others.
UAE Dental Implant Market Analysis
UAE Dental Implant Market was valued at $24.90 Mn in 2023 and is predicted to grow at a CAGR of 10.8% from 2023 to 2030, to $51.10 Mn by 2030. The key drivers of this industry include rising demand for aesthetics, a growing aging population, growing awareness of benefits, and improved dental technology. The industry is primarily dominated by Straumann Group, Dentsply Sirona, Zimmer Biomet Ltd, and Henry Schein Holdings Ltd among others.
Spain Hypersomnia Therapeutics Market Analysis
The Spain Hypersomnia Therapeutics Market was valued at $2.76 Mn in 2023 and is predicted to grow at a CAGR of 5.10% from 2023 to 2030, to $3.91 Mn by 2030. The key drivers of this industry include the rising prevalence of sleep disorders, expanding geriatric population, early detection, and advancement in diagnostic tools. The key players in the industry are Jazz Pharmaceuticals, Teva, Takeda, and Pfizer among others.
UK Chronic Cough Therapeutics Market Analysis
UK Chronic Cough Therapeutics Market was valued at $164 Mn in 2022 and is estimated to reach $263 Mn in 2030, exhibiting a CAGR of 6.1% during the forecast period. The key driver behind the growth of the chronic cough therapeutics market is the prevalent occurrence of chronic respiratory infections, often identified by persistent coughing. Leading participants in this market presently include GlaxoSmithKline, Pfizer, Reckitt Benckiser, Boots, Sanofi, AstraZeneca, Boehringer Ingelheim, Chiesi, Novartis, and Teva Pharmaceutical Industries.
Malaysia MRI Market Analysis
The Malaysia MRI Market was valued at $10.68 Mn in 2023 and is predicted to grow at a CAGR of 6.7% from 2023 to 2030, to $16.81 Mn by 2030. The key drivers of this industry include increasing prevalence of chronic diseases, technological advancements in MRI, and increasing government expenditure. The key players in the industry are Siemens Healthineers, GE Healthcare, Best Contact (M) Sdn Bhd., and Koninklijke Philips NV among others. Malaysia MRI Market Executive Summary The Malaysia MRI Market is at around $10.68 Mn in 2023 and is projected to reach $16.81 Mn in 2030, exhibiting a CAGR of 6.7% during the forecast period.
Brazil Dental Implant Market Analysis
Brazil Dental Implant Market was valued at $124.80 Mn in 2023 and is predicted to grow at a CAGR of 10.8% from 2023 to 2030, to $255.80 Mn by 2030. The key drivers of this industry include growing demand for aesthetics, growing dental awareness, a growing aging population, and improved dental infrastructure. The industry is primarily dominated by Straumann Group, Dentsply Sirona, Zimmer Biomet Ltd, and Henry Schein Holdings Ltd among others.
UK Hypersomnia Therapeutics Market Analysis
The UK Hypersomnia Therapeutics Market was valued at $3.70 Mn in 2023 and is predicted to grow at a CAGR of 4.70% from 2023 to 2030, to $5.10 Mn by 2030. The key drivers of this industry include increasing awareness, lifestyle changes, expanding geriatric population, and early detection. The key players in the industry are GSK, Hoffmann-La Roche Ltd, Sanofi, and Novartis among others.
US Chronic Cough Therapeutics Market Analysis
US Chronic Cough Therapeutics Market was valued at $2646 Mn in 2022 and is estimated to reach $4249 Mn in 2030, exhibiting a CAGR of 6.1% during the forecast period. The key driver behind the growth of the chronic cough therapeutics market is the high prevalence of chronic respiratory infections, as chronic cough commonly signals the presence of such conditions. Presently, leading contributors to this market comprise GlaxoSmithKline (GSK), Pfizer, McNeil Consumer Healthcare (Johnson & Johnson), Procter & Gamble (P&G), Reckitt Benckiser Group, Perrigo Company, Medtech Products Inc., Bionpharma Inc., A. Vogel Canada Inc. and Jamieson Laboratories.
